BRADLEY FOSTER & SARGENT INC/CT - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
BRADLEY FOSTER & SARGENT INC/CT ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$13,067,1010.0%433,9790.0%0.28%0.0%
Q2 2023$13,067,101
+49.6%
433,979
+60.7%
0.28%
+32.2%
Q1 2023$8,736,725
+13.4%
270,069
+0.5%
0.21%
+7.8%
Q4 2022$7,703,486
+140.1%
268,789
+102.0%
0.19%
+116.9%
Q3 2022$3,209,000
-11.4%
133,043
+0.6%
0.09%
-4.3%
Q2 2022$3,620,000
-29.3%
132,207
-1.0%
0.09%
-14.7%
Q1 2022$5,122,000
+20.0%
133,560
+0.2%
0.11%
+22.5%
Q4 2021$4,269,000
+18.8%
133,295
+9.3%
0.09%
+6.0%
Q3 2021$3,594,000
-10.1%
121,940
+3.6%
0.08%
-9.7%
Q2 2021$3,998,000
+6.3%
117,667
+1.7%
0.09%
-2.1%
Q1 2021$3,760,000
+1.8%
115,699
+12.9%
0.10%
-2.1%
Q4 2020$3,693,000
+17.0%
102,522
+27.2%
0.10%
+5.4%
Q3 2020$3,156,000
+667.9%
80,592
+351.9%
0.09%
+475.0%
Q1 2020$411,000
+74.9%
17,835
+121.8%
0.02%
+128.6%
Q4 2019$235,000
+7.8%
8,040
-1.5%
0.01%0.0%
Q3 2019$218,000
+4.3%
8,1650.0%0.01%0.0%
Q2 2019$209,0008,1650.01%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders